denbufylline has been researched along with rolipram in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasugai, S; Miyamoto, K; Ohya, K; Sawanishi, H; Suzuki, H; Suzuki, N; Takagi, K; Waki, Y; Yamamoto, S | 1 |
| Maslen, C; Scott, LC; Souness, JE | 1 |
| Mensah, LM; Murray, KJ; Worby, A | 1 |
| Lugnier, C; Muller, B; Stoclet, JC | 1 |
| Conanan, ND; Ellis, JL | 1 |
| Blaney, F; Finn, P; Phippen, R; Wyatt, M | 1 |
| Beleta, J; Bou, J; Cardelús, I; Cortijo, J; Gristwood, RW; Llenas, J; Morcillo, E | 1 |
| Cardelús, I; Gras, J; Jáuregui, J; Llenas, J; Palacios, JM | 1 |
| Cieslinski, LB; Michell, MP; Ohlstein, EH; Sauermelch, CF; Shiloh, AO; Sulpizio, A; Torphy, TJ; Willette, RN | 1 |
| Chini, CC; Chini, EN; Dousa, TP; Grande, JP | 1 |
| Buckingham, JC; Cover, PO; Kumari, M; Poyser, RH | 1 |
| Poduslo, JF; Walikonis, RS | 1 |
| Giembycz, MA; Seldon, PM | 1 |
| Akuta, K; Hirose, R; Ichimura, M; Manabe, H; Nonaka, H; Ohshima, E; Sato, S; Yanagawa, K | 1 |
14 other study(ies) available for denbufylline and rolipram
| Article | Year |
|---|---|
Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression, Chemical; Heart; Isoenzymes; Male; Models, Chemical; Muscle Relaxation; Myocardium; Phosphodiesterase Inhibitors; Purines; Shrews; Trachea | 1997 |
Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP-specific phosphodiesterase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cell Membrane; Enzyme Activation; Eosinophils; Glutathione; Guinea Pigs; Pyrrolidinones; Rolipram; Solubility; Vanadates; Xanthines | 1992 |
Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cell Fractionation; Guinea Pigs; Kinetics; Milrinone; Muscles; Myocardium; Myofibrils; Pyridazines; Pyridones; Pyrrolidinones; Rats; Rolipram; Xanthines | 1992 |
Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Atenolol; Calcium Chloride; Colforsin; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Reserpine; Rolipram; Stereoisomerism; Xanthines | 1990 |
Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Atropine; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Guanidines; Guinea Pigs; Indomethacin; Isoenzymes; Muscle Relaxation; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Propranolol; Purinones; Pyridazines; Pyrrolidinones; Receptors, Adrenergic; Receptors, Cholinergic; Rolipram; Trachea; Vasoactive Intestinal Peptide; Xanthines | 1995 |
Molecular surface comparison: application to drug design.
Topics: Anti-Bacterial Agents; Computer-Aided Design; Drug Design; Lactams; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Surface Properties; Xanthines | 1993 |
Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Animals; Asthma; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Female; Guinea Pigs; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Theophylline; Xanthines | 1993 |
Inhibition of lipopolysaccharide-induced bowel erythrocyte extravasation in rats, and of mesenteric hypoperfusion in dogs, by phosphodiesterase inhibitors.
Topics: Animals; Dogs; Escherichia coli; Hemodynamics; Ileum; Lipopolysaccharides; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rolipram; Splanchnic Circulation; Xanthines | 1996 |
Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Basilar Artery; Cerebral Arteries; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Drug Evaluation, Preclinical; Ischemic Attack, Transient; Isoenzymes; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prostaglandin Endoperoxides, Synthetic; Pyrrolidinones; Rolipram; Second Messenger Systems; Subarachnoid Hemorrhage; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Xanthines | 1997 |
Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bucladesine; Cell Compartmentation; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Glomerular Mesangium; Kinetics; Mitosis; NADPH Oxidases; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Quinolones; Rats; Rolipram; Signal Transduction; Superoxides; Xanthines | 1997 |
Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Topics: Adrenocorticotropic Hormone; Animals; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Male; Phosphodiesterase Inhibitors; Pituitary-Adrenal System; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Xanthines | 1997 |
Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation, Enzymologic; Male; Myelin Sheath; Nerve Crush; Nerve Regeneration; Phosphoric Diester Hydrolases; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Rolipram; S100 Proteins; Sciatic Nerve; Time Factors; Transcription, Genetic; Xanthines | 1998 |
Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Albuterol; Antibodies; Cholera Toxin; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-10; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; RNA, Messenger; Rolipram; Xanthines | 2001 |
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
Topics: Animals; Benzamides; Binding Sites; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kinetics; Male; Molecular Structure; Naphthyridines; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rolipram; Shrews; Tritium; Vomiting; Xanthines | 2007 |